Mia's Feed
Medical News & Research

Rising Threat of Synthetic Opioids in Australia

Rising Threat of Synthetic Opioids in Australia

Share this article

Australia faces an emerging threat from highly potent synthetic opioids like nitazenes, which are contaminating the drug supply and increasing overdose risks. Enhanced monitoring and harm reduction strategies are urgently needed.

2 min read

Australia is experiencing an increasing infiltration of synthetic opioids into its drug supply, raising significant public health concerns. Recent investigations by the Australian Federal Police have identified nitazenes—highly potent synthetic opioids—in counterfeit pharmaceuticals seized at borders. These substances are chemically similar to fentanyl, which is known for its role in overdose deaths in the United States, with some nitazene compounds being up to 50 times more powerful than fentanyl. A typical onset of action for nitazenes occurs within just two minutes, vastly reducing the window for emergency intervention in overdose situations.

A new study published in the Drug and Alcohol Review highlights the extent of this emerging threat across Australia. It reports the detection of these novel synthetic opioids in every jurisdiction except Tasmania, with at least 22 deaths linked to fentanyl analogs since 2013 and at least 22 nitazene-related fatalities in Victoria since 2021. Despite existing monitoring capacities, rapid advances in nitazene variants challenge the ability of health authorities to identify and respond to these threats in real-time.

Experts emphasize that many individuals may unknowingly consume synthetic opioids, as these substances are increasingly found as contaminants in drugs like MDMA, cocaine, and counterfeit pharmaceuticals. This unintentional exposure heightens the risk of overdose and death, especially among people without a history of opioid use.

To mitigate these dangers, harm reduction strategies such as drug checking services, including pill testing, and expanded availability of naloxone—an opioid overdose reversal medication—are crucial. Currently, drug checking is accessible in the Australian Capital Territory, Victoria, and New South Wales, but other states like Queensland have ceased their services.

Researchers and authorities urge Australia to bolster its preparedness and response mechanisms, aiming to curb the spread and impact of synthetic opioids. Strengthening harm reduction responses and public awareness is imperative to address this escalating crisis.

Source: https://medicalxpress.com/news/2025-05-australia-threats-synthetic-opioids.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Metabolic Insights from Kidney 'Immune Hubs' Open New Therapeutic Avenues

New research reveals how metabolic regulation within kidney immune hubs, called TLSs, offers promising therapeutic and diagnostic opportunities for kidney diseases by focusing on glutathione dynamics and immune cell interactions.

Protein DNM1 Identified as Key Regulator in Ovarian Cancer Metastasis

Research identifies the protein DNM1 as a key regulator of ovarian cancer metastasis, offering new avenues for targeted therapy. Elevated DNM1 levels promote tumor spread by enhancing cell mobility via N-cadherin recycling, presenting promising treatment strategies.

Research Shows Flavor Bans Reduce Youth Vaping but May Impact Cigarette Trends

Flavor bans on e-cigarettes significantly reduce youth and adult vaping, but may slow the decline in cigarette smoking among youth. Research highlights the need for balanced tobacco control strategies.

Enhanced Outcomes in Advanced Triple-Negative Breast Cancer with Combination Therapy

A new study reveals that adding everolimus to carboplatin chemotherapy can significantly extend disease control in advanced triple-negative breast cancer, promising a new treatment approach for this aggressive cancer form.